News Conference News AHA 2023 Full SELECT Results Affirm CV Risk Reduction With Semaglutide in Nondiabetics Todd Neale November 11, 2023
News Conference News ESC 2023 STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function Shelley Wood August 25, 2023
News Daily News EMA Investigating Suicidal Thinking With GLP-1 Drugs for Weight Loss Michael O'Riordan July 12, 2023
News Conference News ADA 2023 Oral, Daily Semaglutide Cuts Pounds in Nondiabetic Patients: OASIS 1 Shelley Wood June 29, 2023
News Daily News Obesity and CVD: New Review Highlights Where Tools and Meds Fall Short Shelley Wood January 31, 2023